Seniors’ Access to Critical Medications Act of 2025

This bill would let some doctors give certain Medicare prescription drugs directly to their patients from the doctor’s office. It creates a time‑limited exception to current rules, from January 1, 2026 through December 31, 2030. To use it, the drug must be a Medicare Part D drug. The patient must already see the doctor or someone in the same group and have had at least one in‑person visit in the past year. The drug can be picked up at the office or sent by mail or courier, and billing must be done by the doctor, the group, or an entity they wholly own. It does not change any other Medicare Part D program rules.

The bill also orders a federal study on pharmacies and doctor office arrangements that might increase drug dispensing after the bill takes effect. The report is due to Congress within three years. It also makes a small change to the Medicare Improvement Fund, lowering it by $18 million.

• Who is affected: Medicare patients and physician group practices that dispense Part D drugs.
• What changes: Allows in‑office dispensing under strict conditions; requires a Government Accountability Office study and report on dispensing patterns; slightly reduces the Medicare Improvement Fund.
• When: January 1, 2026 through December 31, 2030 for the dispensing exception; study report due within three years of enactment.